18
Total investments
13
Early stage
2
Mid stage
0
Late stage
10y
Years active
Portfolio
16 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Nov 2022
At MosaicML, we believe that all organizations should have access to state-of-the art AI capabilities. Our fully managed infrastructure and software tools lets you train and deploy large-scale machine learning models using your own data.
We optimize every layer of the model development process - from algorithms to systems to hardware - so you can get more accurate insights, faster. We’ll help you train the ML models you need with the time and budget you have. Let’s put your data to work.
Series B Investor and Board Observer
Sep 2020
Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.
Series B Investor and Board Observer
Dec 2019
The fastest growing AI-powered SaaS data company in healthcare.
Board Member
Apr 2018
Centivo is a new kind of healthcare company committed to restoring healthcare affordability for American employers and their people.
Founded in 2017, Centivo’s model was designed specifically to curb the inefficiency and waste in today’s employer healthcare market. In partnership with leading local health systems, Centivo’s primary care-centered health plan offers U.S. employers a replacement to traditional health insurance carriers, lowering the total cost of care by 30% or more while delivering tangible value to employers, employees, and its partner health systems.
Centivo delivers on its mission every day for its diverse employer clients across America – from local bakeries and schools to Fortune 100 enterprises.
Seed/Series A Investor and Board Member
Apr 2018
Centivo is a new kind of healthcare company committed to restoring healthcare affordability for American employers and their people.
Founded in 2017, Centivo’s model was designed specifically to curb the inefficiency and waste in today’s employer healthcare market. In partnership with leading local health systems, Centivo’s primary care-centered health plan offers U.S. employers a replacement to traditional health insurance carriers, lowering the total cost of care by 30% or more while delivering tangible value to employers, employees, and its partner health systems.
Centivo delivers on its mission every day for its diverse employer clients across America – from local bakeries and schools to Fortune 100 enterprises.
Series A Investor and Board Member
Dec 2017
Cityblock was founded in 2017 as the first tech-driven provider for communities with complex needs. We deliver better care to where it’s needed most, investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Our tech enables scale by bringing together practical information, coordination, and communication for our members and our care teams.
We are adamant about building a radically better member experience for people living in lower-income neighborhoods that have never been prioritized. And we won’t be satisfied with anything less than transforming the way that health services are delivered in previously underserved communities across the U.S. Join us! cityblock.com/careers
Board Member
Dec 2017
Cityblock was founded in 2017 as the first tech-driven provider for communities with complex needs. We deliver better care to where it’s needed most, investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Our tech enables scale by bringing together practical information, coordination, and communication for our members and our care teams.
We are adamant about building a radically better member experience for people living in lower-income neighborhoods that have never been prioritized. And we won’t be satisfied with anything less than transforming the way that health services are delivered in previously underserved communities across the U.S. Join us! cityblock.com/careers
Seed/Series A Investor and Board Observer
Oct 2017
Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. We connect consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to sexual health, hair care, mental health, skincare, primary care, and more.
With products and services available across all 50 states and Washington, D.C., Hims & Hers is on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. We normalize health & wellness challenges—and innovate on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so we provide access to personalized care designed for results. At our core, our mission is deeply personal—because we too are customers.
In January 2021, the company was listed on the NYSE and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.
Board Observer
Oct 2017
Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. We connect consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to sexual health, hair care, mental health, skincare, primary care, and more.
With products and services available across all 50 states and Washington, D.C., Hims & Hers is on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. We normalize health & wellness challenges—and innovate on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so we provide access to personalized care designed for results. At our core, our mission is deeply personal—because we too are customers.
In January 2021, the company was listed on the NYSE and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.
Series A Investor
Oct 2017
At Devoted Health, we’re on a mission to dramatically improve the health and well-being of older Americans by caring for every person like family. Founded in 2017, weve grown fast and now serve members all across the United States. Weve gathered smart, diverse, and big-hearted people to create a new kind of all-in-one healthcare company — one that combines compassion, health insurance, clinical care, service, and technology -- to deliver a complete and integrated healthcare solution that delivers high quality care that everyone would want for someone they love. Were only just getting started! So join us on this mission: https://devoted.com/careers/
Series B Investor and Board Observer
Jul 2017
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
Board Observer
Jul 2017
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
Series A Investor and Board Member
Aug 2016
At Artemis by Nomi Health, we are striving to help fix healthcare in America. We’re making it easy for self-insured employers to use their own benefits data to reduce spending and improve benefits for their employees.
Because we believe that everyone should have good healthcare they can afford.
Board Member
Aug 2016
At Artemis by Nomi Health, we are striving to help fix healthcare in America. We’re making it easy for self-insured employers to use their own benefits data to reduce spending and improve benefits for their employees.
Because we believe that everyone should have good healthcare they can afford.
Seed/Series A Investor and Board Member
Jul 2016
Docent Health was acquired by Get Well in December 2020. For up-to-date information, please visit the Get Well LinkedIn page: www.linkedin.com/company/getwellnetwork/
Show all 16 investments ↓
Experience · 24 entries
All (24)
Investments (18)
Board (16)
2025
Board Member
2025
At Mercy, care is more than a job - it’s a calling.
Every day, our caregivers bring compassion, skill and purpose to the communities we serve across Arkansas, Kansas, Missouri and Oklahoma. Whether youre building your career at the bedside, in a clinic or supporting care behind the scenes, you’ll find meaningful ways to make an impact - while growing in a way that’s uniquely yours.
As a physician-led, integrated health system with more than 50 hospitals and nearly 1,000 care sites, Mercy combines advanced technology, collaboration and a shared commitment to better care.
Rooted in a faith-based mission and inspired by the legacy of the Sisters of Mercy, our work is guided by a deep sense of purpose - to care for the whole person and serve our communities with compassion and dignity.
Here, you’ll find an environment where you’re supported to grow, connected to a team that cares and empowered to do your best work.
Because at Mercy, there are many paths - but one calling.
2022
Investor
Nov 2022
At MosaicML, we believe that all organizations should have access to state-of-the art AI capabilities. Our fully managed infrastructure and software tools lets you train and deploy large-scale machine learning models using your own data.
We optimize every layer of the model development process - from algorithms to systems to hardware - so you can get more accurate insights, faster. We’ll help you train the ML models you need with the time and budget you have. Let’s put your data to work.
2020
Series B Investor and Board Observer
Sep 2020
Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.
2019
Series B Investor and Board Observer
Dec 2019
The fastest growing AI-powered SaaS data company in healthcare.
2018
Board Member
Apr 2018
Centivo is a new kind of healthcare company committed to restoring healthcare affordability for American employers and their people.
Founded in 2017, Centivo’s model was designed specifically to curb the inefficiency and waste in today’s employer healthcare market. In partnership with leading local health systems, Centivo’s primary care-centered health plan offers U.S. employers a replacement to traditional health insurance carriers, lowering the total cost of care by 30% or more while delivering tangible value to employers, employees, and its partner health systems.
Centivo delivers on its mission every day for its diverse employer clients across America – from local bakeries and schools to Fortune 100 enterprises.
Show all 24 entries ↓
Investment activity
2016–2025 · 18 investments
Recent (last 2 years)Earlier
